Pharsight

1. List of Dsuvia drug patents

Patent Number	Company	Patent Title	Patent Expiry
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8778393	ACELRX PHARMS	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan, 2027 (3 years from now)
US9320710	ACELRX PHARMS	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan, 2027 (3 years from now)
US10342762	ACELRX PHARMS	Small-volume oral transmucosal dosage forms	Jan, 2027 (3 years from now)
US8231900	ACELRX PHARMS	Small-volume oral transmucosal dosage	Jan, 2027 (3 years from now)
US8252328	ACELRX PHARMS	Bioadhesive drug formulations for oral transmucosal delivery	Jan, 2027 (3 years from now)
US9744129	ACELRX PHARMS	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan, 2027 (3 years from now)
US8252329	ACELRX PHARMS	Bioadhesive drug formulations for oral transmucosal delivery	Jan, 2027 (3 years from now)
US8226978	ACELRX PHARMS	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan, 2027 (3 years from now)
US8865211	ACELRX PHARMS	Bioadhesive drug formulations for oral transmucosal delivery	Jan, 2027 (3 years from now)
US10245228	ACELRX PHARMS	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan, 2027 (3 years from now)
US10507180	ACELRX PHARMS	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan, 2027 (3 years from now)
US8535714	ACELRX PHARMS	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Jan, 2027 (3 years from now)
US8778394	ACELRX PHARMS	Small-volume oral transmucosal dosage forms	Jan, 2027 (3 years from now)
US8574189	ACELRX PHARMS	Storage and dispensing devices for administration of oral transmucosal dosage forms	Mar, 2030 (6 years from now)
US10896751	ACELRX PHARMS	Storage and dispensing devices for administration of oral transmucosal dosage forms	Mar, 2030 (6 years from now)
US8202535	ACELRX PHARMS	Small-volume oral transmucosal dosage forms	Oct, 2030 (7 years from now)
US8865743	ACELRX PHARMS	Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain	Oct, 2030 (7 years from now)
US8945592	ACELRX PHARMS	Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same	Jul, 2031 (8 years from now)